SCHEMBL21088372

SCHEMBL21088372

COC(=O)c1ccc(CNC2CCCCC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.67
HRH3 Q9Y5N1 1/20 0.58
NPC1 O15118 1/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
EPHX2 P34913 1/20 0.56
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
EPHX1 P07099 1/20 0.52
POLB P06746 2/20 0.51
LMNA P02545 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.50
SCN1A P35498 1/20 0.50
SCN2A Q99250 1/20 0.50
SCN3A Q9NY46 1/20 0.50
CXCR4 P61073 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5070257 0.98 HDAC1 (0.64) HDAC1HRH3NPC1ALDH1A1SMN1; SMN2
SCHEMBL2734359 0.92 HDAC1 (0.55) HDAC1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2651787 0.88 HDAC1 (0.51) HDAC1ALDH1A1SMN1; SMN2EPHX1LMNA
SCHEMBL2659813 0.87 HDAC1 (0.50) HDAC1ALDH1A1SMN1; SMN2EPHX1LMNA
SCHEMBL2659811 0.87 HDAC1 (0.50) HDAC1ALDH1A1SMN1; SMN2EPHX1LMNA
SCHEMBL2652054 0.86 NPC1 (0.52) HDAC1HRH3NPC1ALDH1A1SMN1; SMN2
SCHEMBL2652091 0.85 HDAC1 (0.49) HDAC1ALDH1A1SMN1; SMN2EPHX1LMNA
SCHEMBL2653241 0.84 LTA4H (0.50) HDAC1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL18172649 0.84 HDAC1 (0.48) HDAC1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4092949 0.84 ALDH1A1 (0.60) HDAC1ALDH1A1EPHX1LMNALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286172-B1 LSD1 INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2019-06-12 EP disclosed